2Ding S,Zhang M,Zhao Y,et al. The role of carotid plaque vul-nerability and inflammation in the pathogenesis of acute ische-mic stroke[J]. Am J Med Sci,2008,336(1) ;27-31.
3Abu Rahma AF, Wulu JT Jr,Crotty B. Carotid plaque ultra-sonic heterogeneity and severity of stenosis[J]. Stroke, 2002,33(7): 1 772-1 775.
4Yeh ET. High-sensitivity C-reactive protein as a risk assess-ment tool for cardiovascular disease[J]. Clin Cardiol, 2005 , 28(9):408-412.
5Williams TN,Zhang CX. Game BA, et al. C-reactive pro-teinstimulatesMMP-1 expression in U937 histiocytes through Fc[gamma] R H and extracellular signal-regulated kinase path-way; an implication of crp involvement in plaque destablization[J]. Arterioscler Thromb Vase Biol,2004, 24(1) : 61-66.
6Willusion JT,Ridker PM. Inflammation as a cardiovascular riskfactor[J]. Circulation,2004,109(21) :110-112.
7Iwamoto T,Shimizu S,Takasaki M. Long-term effects ofli-poprotein (a) on carotid atherosclerosis in elderly Japanese[J].J Gerontol A Biol Sci Med Sci,2004,59 (1): 62-67.
3Assmann G,Schulte H. The prospective cardiovascular munster(PROCAM) study: preralence of hyperlipidemia in patients with hypertension and diadetes mellitus and relationship to coronary heart disease[J].Am Heart J,1998,116:1713.
4Lakka TA, Lakka HM, Salonen R. Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men[J].Atheroslerosis,2001,154:479.
5Magyar MT, Paragh G, Katona E, et al. Serum cholesterols have a more important role than triglycerides in determining intima-media thickness of the common carotid artery in subjects younger than 55 years of age[J].J ultrasound Med,2004,23:1161-1169
6Colhoun HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the collaborative atorvastatin diabetes study (CARDS): multicentre randomised placebo-controlled trial[J].Lancet,2004,364:685-696.
7Haffner SM, Agostino RD Jr, Saad MF, et al. carotid artery atherosclerosis in type 2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (The Insulin Resistance Atheroslerosis Study)[J].Am J Cardiol,2000,85:1395.
